Post-approval studies (Phase 4)Study completedNCT01257815
What this trial is testing
Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Who this might be right for
Diabetic RetinopathyMacular Oedema
Novartis Pharmaceuticals 111